139 related articles for article (PubMed ID: 11058865)
1. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule.
Satoh S; Hinoda Y; Hayashi T; Burdick MD; Imai K; Hollingsworth MA
Int J Cancer; 2000 Nov; 88(4):507-18. PubMed ID: 11058865
[TBL] [Abstract][Full Text] [Related]
2. Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 cells.
Suwa T; Hinoda Y; Makiguchi Y; Takahashi T; Itoh F; Adachi M; Hareyama M; Imai K
Int J Cancer; 1998 May; 76(3):377-82. PubMed ID: 9579575
[TBL] [Abstract][Full Text] [Related]
3. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line.
Kohlgraf KG; Gawron AJ; Higashi M; Meza JL; Burdick MD; Kitajima S; Kelly DL; Caffrey TC; Hollingsworth MA
Cancer Res; 2003 Aug; 63(16):5011-20. PubMed ID: 12941828
[TBL] [Abstract][Full Text] [Related]
4. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
Tsutsumida H; Swanson BJ; Singh PK; Caffrey TC; Kitajima S; Goto M; Yonezawa S; Hollingsworth MA
Clin Cancer Res; 2006 May; 12(10):2976-87. PubMed ID: 16707592
[TBL] [Abstract][Full Text] [Related]
5. High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.
Kitamura N; Iwamura T; Taniguchi S; Yamanari H; Kawano MA; Hollingsworth K; Setoguchi T
Clin Exp Metastasis; 2000; 18(7):561-71. PubMed ID: 11688961
[TBL] [Abstract][Full Text] [Related]
6. Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth.
Makiguchi Y; Hinoda Y; Imai K
Jpn J Cancer Res; 1996 May; 87(5):505-11. PubMed ID: 8641988
[TBL] [Abstract][Full Text] [Related]
7. MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion.
Swanson BJ; McDermott KM; Singh PK; Eggers JP; Crocker PR; Hollingsworth MA
Cancer Res; 2007 Nov; 67(21):10222-9. PubMed ID: 17974963
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231].
Lu L; Deng HY; Fan WK
Ai Zheng; 2004 Nov; 23(11):1294-6. PubMed ID: 15522176
[TBL] [Abstract][Full Text] [Related]
9. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MUC1 reconfigures the binding properties of tumor cells.
McDermott KM; Crocker PR; Harris A; Burdick MD; Hinoda Y; Hayashi T; Imai K; Hollingsworth MA
Int J Cancer; 2001 Dec; 94(6):783-91. PubMed ID: 11745478
[TBL] [Abstract][Full Text] [Related]
12. MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices.
Hudson MJ; Stamp GW; Hollingsworth MA; Pignatelli M; Lalani EN
Am J Pathol; 1996 Mar; 148(3):951-60. PubMed ID: 8774149
[TBL] [Abstract][Full Text] [Related]
13. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
[TBL] [Abstract][Full Text] [Related]
14. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
15. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth.
Yuan Z; Liu X; Wong S; Machan JT; Chung MA
J Surg Res; 2009 Nov; 157(1):e39-46. PubMed ID: 19482310
[TBL] [Abstract][Full Text] [Related]
16. Differential glycosylation of MUC1 in tumors and transfected epithelial and lymphoblastoid cell lines.
Poland PA; Kinlough CL; Rokaw MD; Magarian-Blander J; Finn OJ; Hughey RP
Glycoconj J; 1997 Jan; 14(1):89-96. PubMed ID: 9076518
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells.
Porowska H; Paszkiewicz-Gadek A; Anchim T; Wolczynski S; Gindzienski A
Int J Mol Med; 2004 Mar; 13(3):459-64. PubMed ID: 14767580
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
Deharvengt S; Wack S; Aprahamian M; Hajri A
J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
[TBL] [Abstract][Full Text] [Related]
19. Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours.
Kalra AV; Campbell RB
Eur J Cancer; 2009 Jan; 45(1):164-73. PubMed ID: 19046630
[TBL] [Abstract][Full Text] [Related]
20. N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.
Nishimori I; Perini F; Mountjoy KP; Sanderson SD; Johnson N; Cerny RL; Gross ML; Fontenot JD; Hollingsworth MA
Cancer Res; 1994 Jul; 54(14):3738-44. PubMed ID: 8033093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
